Ladyzhets, B. (2021, November 9). The U.S. Is Relying On Other Countries’ Data To Make Its Booster Shot Decisions. FiveThirtyEight. https://fivethirtyeight.com/features/the-u-s-is-relying-on-other-countries-data-to-make-its-booster-shot-decisions/

Pearson, C. (2021, September 27). New Study Finds A Huge Perk Of Getting Vaccinated After Having COVID-19. HuffPost UK. https://www.huffpost.com/entry/study-covid-vaccine_l_6151dbbde4b098483a792e18

Beaumont, P. (2021, December 17). T-cells in Pfizer Covid jab recipients stay robust against severe illness. The Guardian. https://www.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research

Pozzetto, B., Legros, V., Djebali, S., Barateau, V., Guibert, N., Villard, M., Peyrot, L., Allatif, O., Fassier, J.-B., Massardier-Pilonchéry, A., Brengel-Pesce, K., Yaugel-Novoa, M., Denolly, S., Boson, B., Bourlet, T., Bal, A., Valette, M., Andrieu, T., Lina, B., … Trouillet-Assant, S. (2021). Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination. Nature, 1–9. https://doi.org/10.1038/s41586-021-04120-y

Andrews, N., Stowe, J., Kirsebom, F., Gower, C., Ramsay, M., & Lopez Bernal, J. (2021). Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: Test negative case-control study [Preprint]. Epidemiology. https://doi.org/10.1101/2021.11.15.21266341

Anthes, E. (2021, August 19). What to Know About Boosters if You Got the Johnson & Johnson Vaccine. The New York Times. https://www.nytimes.com/2021/08/19/health/coronavirus-johnson-vaccine-booster.html

Kozlov, M. (2021). Waning COVID super-immunity raises questions about Omicron. Nature. https://doi.org/10.1038/d41586-021-03674-1

Zimmer, C. (2021, June 6). We’ll Probably Need Booster Shots for Covid-19. But When? And Which Ones? The New York Times. https://www.nytimes.com/2021/06/06/science/covid-vaccine-boosters.html

Davis, N. (2021, October 18). Valneva Covid vaccine could be as effective as Oxford jab, study suggests. The Guardian. https://www.theguardian.com/society/2021/oct/18/valneva-covid-vaccine-could-be-as-effective-as-oxford-jab-study-suggests

Dowdy, D. (2021, September 21). On the J&J booster news, keep in mind: 1. Median follow-up since 2nd dose was just 36 days, 2. Efficacy vs moderate COVID was 75% globally, and 3. Total number of cases in the US was 15. Please don’t take this to mean that a 2nd dose provides long-term increase in protection. Https://t.co/RnqDNBmwuD [Tweet]. @davidwdowdy. https://twitter.com/davidwdowdy/status/1440323242942554122

Eric Topol. (2021, October 27). 'The benefit of a third [booster] dose in reducing transmission is sizeable and increases with vaccine coverage and contact rates among individuals." https://medrxiv.org/content/10.1101/2021.10.25.21265500v1 by @billygardner and @DiseaseEcology https://t.co/zAZcJgF1nJ [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1453153076165021696

SciBeh on TikTok. (n.d.). TikTok. Retrieved May 1, 2022, from https://www.tiktok.com/@scibeh/video/7000432022325939462?_d=secCgYIASAHKAESPgo8GPEbKKbiFu7Sl2GNp5smO9sRKR2i7T5NTDwl4HWTKaZGRf75%2Fen19g6Ynx4sySqiFdP%2FAxK5P2FKxB2lGgA%3D&checksum=642cb589182f25581f96731dab7ec4230c588e19848b1d11f8ed3b0153621f1a&language=en&preview_pb=0&sec_user_id=MS4wLjABAAAAQO7yXdTFpV__NrPqBQFzpXogb1sNcBur9IEDgrh7c6Q0jw6frBEkVsMRKayWbEOa&share_app_id=1233&share_item_id=7000432022325939462&share_link_id=106DAE19-F018-48C2-9AE6-0524EF966F2E&source=h5_m&timestamp=1630227742&tt_from=copy&u_code=dj58gf6708e20h&user_id=6973976044836717574&utm_campaign=client_share&utm_medium=ios&utm_source=copy&_r=1

Levine-Tiefenbrun, M., Yelin, I., Alapi, H., Katz, R., Herzel, E., Kuint, J., Chodick, G., Gazit, S., Patalon, T., & Kishony, R. (2021). Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nature Medicine, 1–3. https://doi.org/10.1038/s41591-021-01575-4

Eric Topol. (2021, June 9). Despite increasing incentives, the US vaccination campaign is really struggling. Notably, the top 5 states are approaching 60% total population fully vaccinated which should provide strong protection vs the delta variant. A different story for the bottom 5 states @OurWorldInData https://t.co/boqk3Khhuc [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1402413221667954690

Gregory Travis -- “The Duke of Mild” (TM). (2022, January 14). When you realize you’ve gone too far https://t.co/a1CutK1uMo [Tweet]. @greg_travis. https://twitter.com/greg_travis/status/1481950558017794050

Prof. Shane Crotty. (2021, October 15). And here https://t.co/aDPrQ17AUD [Tweet]. @profshanecrotty. https://twitter.com/profshanecrotty/status/1449030846711681025

BNO/Medriva Newsroom [@medriva]. (2021, November 26). South Africa’s health minister says, based on a small sample of Omicron cases, the majority of hospital patients are unvaccinated: ‘It indicates that the vaccines are providing protection’ [Tweet]. Twitter. https://twitter.com/medriva/status/1464327805836083201

CDC. (2022, February 4). A new @CDCMMWR study shows that people who reported always wearing masks or respirators in indoor public settings in California were less likely to test positive for #COVID19 compared with those who reported not wearing a face covering. Learn more. Http://bit.ly/MMWR7106 https://t.co/6UJ9cs60NK [Tweet]. @CDCgov. https://twitter.com/CDCgov/status/1489675180242870278

ReconfigBehSci on Twitter: ‘RT @PeterHotez: I’m trying to reconcile Pfizer’s optimistic statements about 3rd dose protection against omicron https://t.co/mIWDowkDW6 v…’ / Twitter. (n.d.). Retrieved 29 March 2022, from https://twitter.com/SciBeh/status/1468568425308078088

ReconfigBehSci. (2022, January 26). .....Those were the days [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1486397585829027847

Mar 03, M. V. B. | N. W. | C. N. | & 2022. (n.d.). Third vaccine dose boosts Omicron protection, with some waning. CIDRAP. Retrieved 7 March 2022, from https://www.cidrap.umn.edu/news-perspective/2022/03/third-vaccine-dose-boosts-omicron-protection-some-waning

Gregg Gonsalves. (2022, January 30). Once again ⁦@DouthatNYT⁩ misframes a debate for his own partisan goals. 1/ https://t.co/Hi7r4HcoAl [Tweet]. @gregggonsalves. https://twitter.com/gregggonsalves/status/1487772523420954625

Altarawneh, H. N., Chemaitelly, H., Hasan, M. R., Ayoub, H. H., Qassim, S., AlMukdad, S., Coyle, P., Yassine, H. M., Al-Khatib, H. A., Benslimane, F. M., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., … Abu-Raddad, L. J. (2022). Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMc2200133

Freja Kirsebom. (2022, January 7). Today we publish our latest analysis where we stratify by age to investigate vaccine effectiveness (VE) against Omicron in adults aged 65 years and older in England. Https://t.co/y73uto6kll 1/14 [Tweet]. @freja_kirsebom. https://twitter.com/freja_kirsebom/status/1479528228079509516

Dr. Peter Hotez: Omicron is like a fast-moving freight train. (n.d.). MSN. Retrieved February 20, 2022, from https://www.msn.com/en-us/news/us/dr-peter-hotez-omicron-is-like-a-fast-moving-freight-train/vi-AARPfVG

Eric Feigl-Ding. (2022, January 13). WATCH📺—Despite 97.5% of all adults in England🏴󠁧󠁢󠁥󠁮󠁧󠁿 with antibodies to #COVID19 (via vax/infection)–hospitalizations still surging. Why? Because variants like #Omicron are adapting. Need multivalent vax, plus ➡️N95 & ventilation are agnostic to variants—Key! Https://t.co/gDNRJIWojX [Tweet]. @DrEricDing. https://twitter.com/DrEricDing/status/1481732793482813443

Yong, E. (2022, February 16). The Millions of People Stuck in Pandemic Limbo. The Atlantic. https://www.theatlantic.com/health/archive/2022/02/covid-pandemic-immunocompromised-risk-vaccines/622094/

How cherry-picking science became the center of the anti-mask movement. (2022, February 14). Gothamist. https://gothamist.com

Living with COVID-19: How the virus could turn into the common cold, or something far worse. (2022, January 9). The Mercury News. https://www.mercurynews.com/2022/01/09/living-with-covid-19-how-the-virus-could-turn-into-the-common-cold-or-something-far-worse

News ·, A. M. · C. (2022, January 15). Canadian COVID-19 vaccine study seized on by anti-vaxxers—Highlighting dangers of early research in pandemic | CBC News. CBC. https://www.cbc.ca/news/health/covid-19-vaccine-study-omicron-anti-vaxxers-1.6315890

Academics: Viral Evolution Scenarios, 10 February 2022. (n.d.). GOV.UK. Retrieved February 14, 2022, from https://www.gov.uk/government/publications/academics-viral-evolution-scenarios-10-february-2022

Grubaugh, N. D., Hodcroft, E. B., Fauver, J. R., Phelan, A. L., & Cevik, M. (2021). Public health actions to control new SARS-CoV-2 variants. Cell, 184(5), 1127–1132. https://doi.org/10.1016/j.cell.2021.01.044

Mahase, E. (2022). Covid-19: What do we know about omicron sublineages? BMJ, 376, o358. https://doi.org/10.1136/bmj.o358

Peña-Hernández, M. A., Klein, J., Malik, A. A., Coppi, A., Kalinich, C., Vogels, C. B. F., Silva, J., Initiative, Y. S.-C.-2 G. S., Peaper, D. R., Landry, M.-L., Wilen, C., Grubaugh, N. D., Schulz, W., Omer, S. B., & Iwasaki, A. (2022). Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals (p. 2021.12.28.21268460). medRxiv. https://doi.org/10.1101/2021.12.28.21268460

Afkhami, S., D’Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., Wang, F., Ang, J. C., Zganiacz, A., Sankar, U., Kazhdan, N., Koenig, J. F. E., Phelps, A., Gameiro, S. F., Tang, S., … Xing, Z. (2022). Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell, S0092867422001453. https://doi.org/10.1016/j.cell.2022.02.005

Deepti Gurdasani. (2022, February 9). I don’t even know what to say. There were 2.8 million people estimated to have prevalent infection in the last ONS survey. 1 in 19 people in the community in England. ~1,800 deaths/wk in the UK. Removing requirements for self-isolation will lead to preventable illness & death.🧵 [Tweet]. @dgurdasani1. https://twitter.com/dgurdasani1/status/1491426843135655936

Willett, J. D. S. (n.d.). Omicron: Vaccines remain the best defence against this COVID-19 variant and others. The Conversation. Retrieved February 8, 2022, from http://theconversation.com/omicron-vaccines-remain-the-best-defence-against-this-covid-19-variant-and-others-174195

Krutika Kuppalli, MD FIDSA. (2022, January 14). If you had #COVID19 once you can get it again (and again). Risk of reinfection in England with #Omicron was ~5.4 fold higher compared to #Delta The relative risk were 6.36 & 5.02 for unvaxxd & vaxxd cases—Implies protection against reinfection by Omicron may be as low as 19% [Tweet]. @KrutikaKuppalli. https://twitter.com/KrutikaKuppalli/status/1482074117742288898

Campbell, D., & Davis, N. (2022, January 14). Covid booster jabs in England to be thrown away as demand falls. The Guardian. https://www.theguardian.com/society/2022/jan/14/covid-booster-jabs-in-england-to-be-thrown-away-as-demand-falls

Jorge A. Caballero, MD (jorgecaballero.eth). (2022, January 10). 🧵/ I just spoke with two journalists about data that shows how the U.S. healthcare system is collapsing before our eyes. The million dollar question during both interviews was, “What else could we be doing right now?” The answer: Flatten the hospitalization curve. Now. [Tweet]. @DataDrivenMD. https://twitter.com/DataDrivenMD/status/1480607009867132928

Yaneer Bar-Yam on Twitter. (n.d.). Twitter. Retrieved February 7, 2022, from https://twitter.com/yaneerbaryam/status/1474091037861761026

Seth Trueger. (2022, February 4). “Many drivers are complaining they have to use brakes despite wearing their seatbelts at all times” https://t.co/gXWiiaJrN9 [Tweet]. @MDaware. https://twitter.com/MDaware/status/1489491410990546950

Devlin, H., & correspondent, H. D. S. (2022, February 3). Novavax Covid vaccine approved for use in over-18s in UK. The Guardian. https://www.theguardian.com/society/2022/feb/03/novavax-covid-vaccine-approved-for-use-in-over-18s-in-uk

Adam, D. (2022). Will Omicron end the pandemic? Here’s what experts say. Nature, 602(7895), 20–21. https://doi.org/10.1038/d41586-022-00210-7

ScienceUpFirst, LaScienced’Abord. (2022, February 1). Got Omicron? You are not alone! See our thread on what we know so far 👇 🧵 [1/11] #ScienceUpFirst https://t.co/7Hi3lHo5LS [Tweet]. @ScienceUpFirst. https://twitter.com/ScienceUpFirst/status/1488601396421316613

Tayag, Y. (2022, January 31). What causes long Covid? Scientists are zeroing in on the answer. Vox. https://www.vox.com/22906853/omicron-long-covid-vaccinated-symptoms-cause

Early data indicate vaccines still protect against Omicron’s sister variant, BA.2. (2022, January 28). STAT. https://www.statnews.com/2022/01/28/early-data-indicate-vaccines-still-protect-against-omicrons-sister-variant-ba-2/

Evershed, N. (n.d.). The simple numbers every government should use to fight anti-vaccine misinformation. The Guardian. Retrieved January 30, 2022, from https://www.theguardian.com/news/datablog/ng-interactive/2022/jan/28/the-simple-numbers-every-government-should-use-to-fight-anti-vaccine-misinformation

Taylor, L. (2022). Covid-19: CoronaVac immunity is strongest after boosting with a different vaccine. BMJ, 376, o210. https://doi.org/10.1136/bmj.o210

Male, V. (2022). Menstruation and covid-19 vaccination. BMJ, 376, o142. https://doi.org/10.1136/bmj.o142

“Endemic” Covid? The pandemic will only be over when the world is jabbed. (2022, January 15). Inews.Co.Uk. https://inews.co.uk/news/politics/endemic-covid-the-pandemic-will-only-be-over-when-the-world-is-jabbed-1402691

Reuters. (2022, January 25). Israel mulls offering 4th COVID vaccine dose to all adults. Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/israel-mulls-offering-4th-covid-vaccine-dose-all-adults-2022-01-25/

Backed By Science: Here’s How We Can Eliminate COVID-19 - Health Policy Watch. (2022, January 23). https://healthpolicy-watch.news/93258-2/

Crane, M., & University, T. O. S. (n.d.). Vaccine hesitance dropped faster among Blacks, study finds. Retrieved January 24, 2022, from https://medicalxpress.com/news/2022-01-vaccine-hesitance-faster-blacks.html

Nicholas, J., & Evershed, N. (2022, January 21). Australia has had its deadliest day yet of the pandemic – here’s what we know about who is dying. The Guardian. https://www.theguardian.com/australia-news/datablog/2022/jan/21/australia-has-had-its-deadliest-day-yet-covid-omicron-heres-what-we-know-about-who-is-dying

Tsukuba, U. of. (n.d.). Vaccine hesitancy changes over time: Attitudes toward vaccines during the COVID-19 pandemic. Retrieved January 18, 2022, from https://medicalxpress.com/news/2022-01-vaccine-hesitancy-attitudes-vaccines-covid-.html

Halliday, J., & correspondent, J. H. N. of E. (2022, January 17). ‘Christmas was awful’: On the Omicron frontline at the Royal Preston hospital. The Guardian. https://www.theguardian.com/world/2022/jan/17/christmas-was-awful-on-the-omicron-frontline-at-the-royal-preston-hospital

Kirby, J. (2021, December 23). Omicron collides with a struggling global vaccination campaign. Vox. https://www.vox.com/22846774/omicron-global-vaccines-covronavirus-covid-19

Yong, E. (2021, December 16). America Is Not Ready for Omicron. The Atlantic. https://www.theatlantic.com/health/archive/2021/12/america-omicron-variant-surge-booster/621027/

CNN, B. M. H. (n.d.). Holiday travel heats up as the Omicron situation unfolds. CNN. Retrieved January 16, 2022, from https://www.cnn.com/travel/article/holiday-travel-omicron-2021/index.html

Connolly, K. (2021, December 28). German court rules disabled people must be protected in Covid triage cases. The Guardian. https://www.theguardian.com/world/2021/dec/28/german-court-disabled-people-covid-triage

Unvaccinated COVID-19 hospitalizations cost billions of dollars. (n.d.). Peterson-KFF Health System Tracker. Retrieved January 14, 2022, from https://www.healthsystemtracker.org/brief/unvaccinated-covid-patients-cost-the-u-s-health-system-billions-of-dollars/

Prof. Gavin Yamey MD MPH. (2022, January 7). Thank you @j_g_allen for continuing to advocate for childhood vaccination & for sharing evidence on masks Yesterday, the U.S. saw a record number of COVID-19 pediatric hospital admissions, almost 1,000 Unvaxxed kids are 10 X more likely to be hospitalized than vaxxed kids 1/2 [Tweet]. @GYamey. https://twitter.com/GYamey/status/1479265484562386944

Jennifer Cohn ✍🏻 📢. (2022, January 11). This chart says it all. If u got double vaccinated early on & are not yet boosted, ur effectively unvaccinated against Omicron infection. Thus, many adults & teens are effectively unvaccinated against infection. Kids got vaccinated recently & thus may be in a safer position. 1/ [Tweet]. @jennycohn1. https://twitter.com/jennycohn1/status/1481034404260581377

France joins other EU countries in toughening rules for COVID pass. (2022, January 6). POLITICO. https://www.politico.eu/article/french-parliament-approves-covid-vaccine-pass/

Dolgin, E. (2022). Omicron thwarts some of the world’s most-used COVID vaccines. Nature. https://doi.org/10.1038/d41586-022-00079-6

Geddes, L., & correspondent, L. G. S. (2022, January 11). Will Covid-19 become less dangerous as it evolves? The Guardian. https://www.theguardian.com/world/2022/jan/11/will-covid-19-become-less-dangerous-as-it-evolves

Omicron largely evades immunity from past infection or two vaccine doses | Imperial News | Imperial College London. (n.d.). Imperial News. Retrieved January 12, 2022, from https://www.imperial.ac.uk/news/232698/omicron-largely-evades-immunity-from-past/

Zambrano, L. D. (2022). Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years—United States, July–December 2021. MMWR. Morbidity and Mortality Weekly Report, 71. https://doi.org/10.15585/mmwr.mm7102e1

Sidik, S. M. (2022). Immunity against Omicron from breakthrough infection could be a matter of timing. Nature. https://doi.org/10.1038/d41586-022-00004-x